Drug Trial Radar · NCT06979505
GV101 in Healthy Obese Participants
Last checked: Nov 19, 2026Latest source record: Feb 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
131
Actual
Start
Jun 30, 2025
Primary completion
Jan 28, 2026
Study completion Jan 28, 2026
Sponsor
- Lead sponsor
- Graviton Bioscience CorporationIndustry
- Sponsor type
- Industry
- First posted
- May 20, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to evaluate the efficacy and safety of GV101 for weight loss over a range of doses in participants with obesity. The primary efficacy endpoint is the mean percent change in body weight from baseline at Week 16 in each treated group as compared with placebo.
Conditions
- Weight Management
Interventions
GV101Drug
GV101 suspension
GV101 placeboDrug
GV101 placebo suspension
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean percent change in body weight from baseline at Week 16 in each treated group as compared with placeboTime frame: 16 weeks
Locations
20 sites in 2 countries. Site status is shown where the registry gives one.
Lakeview Clinical Research, LLC
Guntersville, Alabama
Arizona Clinical Trials
Tucson, Arizona
Catalina Research Institute, LLC
Montclair, California
Encompass Clinical Research
Spring Valley, California
Louisville Metabolic and Atherosclerosis Research Center (L-MARC)
Louisville, Kentucky
Tandem Clinical Research
Marrero, Louisiana
Study Metrix Research
City of Saint Peters, Missouri
Kansas City Research Institute
Kansas City, Missouri
Mercury Street Medical
Butte, Montana
Hassman Research Institute
Berlin, New Jersey
Coastal Research Institute, LLC
Fayetteville, North Carolina
Lillestol Research, LLC
Fargo, North Dakota
Velocity Clinical Research - Cleveland
Cleveland, Ohio
Velocity Clinical Research - Dallas
Dallas, Texas
Advanced Research Institute - Ogden
Ogden, Utah
Chrysalis Clinical Research
St. George, Utah
Hadassah Medical Center Ein Karem
Jerusalem, Israel, Israel
Hasharon Hospital
Petah Tikva, Israel, Israel
Rabin Medical Center, Beilinson Hospital
Petah Tikva, Israel, Israel
Sheba Medical Center
Tel HaShomer, Israel, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.